SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-23-066803
Filing Date
2023-11-29
Accepted
2023-11-29 16:53:41
Documents
2
Period of Report
2023-11-27

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1525
2 EX-24.1 krro-ex24_1.htm EX-24.1 10613
  Complete submission text file 0000950170-23-066803.txt   13660
Mailing Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139 617-468-1900
Korro Bio, Inc. (Issuer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KORRO BIO, INC. ONE KENDALL SQUARE, BUILDING 600-700 CAMBRIDGE MA 02139
Business Address
Meyers Rachel (Reporting) CIK: 0002001472 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39062 | Film No.: 231453035